IRF-3 was also involved in lung cancer that decreased and mutated IRF-3 gene expressions were found in non-small-cell lung cancer (NSCLC) patients, altering the immunoregulatory function in tumorigenesis [7, 8]. Here, IRF3 is linked to lung carcinoma.